Blood-brain barrier disruption for the delivery of non-infectious viral vectors and proteins, preliminary study

Josquin Foiret, Hua Zhang, Brett Z. Fite, Lisa Mahakian, Sarah Tam, David Segal, Katherine W. Ferrara

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Human studies aimed at opening the blood brain barrier (BBB) to deliver therapeutic agents through a combination of focused ultrasound (US) and microbubbles (MB) are currently underway [1]. Our goal was to develop an US-guided BBB opening system capable of steering the US beam throughout the rodent brain and registering the coordinates with high field MRI. Our ultimate goal is to deliver therapy for Angelman Syndrome which requires the ability to deliver protein or adeno-associated virus (AAV) across the BBB over a large field of view. We sought to interface a modular imaging and therapeutic array capable of 3D electronic steering of the therapeutic beam to the Verasonics and MRI.

Original languageEnglish (US)
Title of host publication2017 IEEE International Ultrasonics Symposium, IUS 2017
PublisherIEEE Computer Society
ISBN (Electronic)9781538633830
DOIs
StatePublished - Oct 31 2017
Event2017 IEEE International Ultrasonics Symposium, IUS 2017 - Washington, United States
Duration: Sep 6 2017Sep 9 2017

Other

Other2017 IEEE International Ultrasonics Symposium, IUS 2017
CountryUnited States
CityWashington
Period9/6/179/9/17

Fingerprint

blood-brain barrier
delivery
proteins
rodents
viruses
field of view
brain
therapy
electronics

ASJC Scopus subject areas

  • Acoustics and Ultrasonics

Cite this

Foiret, J., Zhang, H., Fite, B. Z., Mahakian, L., Tam, S., Segal, D., & Ferrara, K. W. (2017). Blood-brain barrier disruption for the delivery of non-infectious viral vectors and proteins, preliminary study. In 2017 IEEE International Ultrasonics Symposium, IUS 2017 [8092098] IEEE Computer Society. https://doi.org/10.1109/ULTSYM.2017.8092098

Blood-brain barrier disruption for the delivery of non-infectious viral vectors and proteins, preliminary study. / Foiret, Josquin; Zhang, Hua; Fite, Brett Z.; Mahakian, Lisa; Tam, Sarah; Segal, David; Ferrara, Katherine W.

2017 IEEE International Ultrasonics Symposium, IUS 2017. IEEE Computer Society, 2017. 8092098.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Foiret, J, Zhang, H, Fite, BZ, Mahakian, L, Tam, S, Segal, D & Ferrara, KW 2017, Blood-brain barrier disruption for the delivery of non-infectious viral vectors and proteins, preliminary study. in 2017 IEEE International Ultrasonics Symposium, IUS 2017., 8092098, IEEE Computer Society, 2017 IEEE International Ultrasonics Symposium, IUS 2017, Washington, United States, 9/6/17. https://doi.org/10.1109/ULTSYM.2017.8092098
Foiret J, Zhang H, Fite BZ, Mahakian L, Tam S, Segal D et al. Blood-brain barrier disruption for the delivery of non-infectious viral vectors and proteins, preliminary study. In 2017 IEEE International Ultrasonics Symposium, IUS 2017. IEEE Computer Society. 2017. 8092098 https://doi.org/10.1109/ULTSYM.2017.8092098
Foiret, Josquin ; Zhang, Hua ; Fite, Brett Z. ; Mahakian, Lisa ; Tam, Sarah ; Segal, David ; Ferrara, Katherine W. / Blood-brain barrier disruption for the delivery of non-infectious viral vectors and proteins, preliminary study. 2017 IEEE International Ultrasonics Symposium, IUS 2017. IEEE Computer Society, 2017.
@inproceedings{0a1a8ba8738d42d89587238cc2277c52,
title = "Blood-brain barrier disruption for the delivery of non-infectious viral vectors and proteins, preliminary study",
abstract = "Human studies aimed at opening the blood brain barrier (BBB) to deliver therapeutic agents through a combination of focused ultrasound (US) and microbubbles (MB) are currently underway [1]. Our goal was to develop an US-guided BBB opening system capable of steering the US beam throughout the rodent brain and registering the coordinates with high field MRI. Our ultimate goal is to deliver therapy for Angelman Syndrome which requires the ability to deliver protein or adeno-associated virus (AAV) across the BBB over a large field of view. We sought to interface a modular imaging and therapeutic array capable of 3D electronic steering of the therapeutic beam to the Verasonics and MRI.",
author = "Josquin Foiret and Hua Zhang and Fite, {Brett Z.} and Lisa Mahakian and Sarah Tam and David Segal and Ferrara, {Katherine W.}",
year = "2017",
month = "10",
day = "31",
doi = "10.1109/ULTSYM.2017.8092098",
language = "English (US)",
booktitle = "2017 IEEE International Ultrasonics Symposium, IUS 2017",
publisher = "IEEE Computer Society",

}

TY - GEN

T1 - Blood-brain barrier disruption for the delivery of non-infectious viral vectors and proteins, preliminary study

AU - Foiret, Josquin

AU - Zhang, Hua

AU - Fite, Brett Z.

AU - Mahakian, Lisa

AU - Tam, Sarah

AU - Segal, David

AU - Ferrara, Katherine W.

PY - 2017/10/31

Y1 - 2017/10/31

N2 - Human studies aimed at opening the blood brain barrier (BBB) to deliver therapeutic agents through a combination of focused ultrasound (US) and microbubbles (MB) are currently underway [1]. Our goal was to develop an US-guided BBB opening system capable of steering the US beam throughout the rodent brain and registering the coordinates with high field MRI. Our ultimate goal is to deliver therapy for Angelman Syndrome which requires the ability to deliver protein or adeno-associated virus (AAV) across the BBB over a large field of view. We sought to interface a modular imaging and therapeutic array capable of 3D electronic steering of the therapeutic beam to the Verasonics and MRI.

AB - Human studies aimed at opening the blood brain barrier (BBB) to deliver therapeutic agents through a combination of focused ultrasound (US) and microbubbles (MB) are currently underway [1]. Our goal was to develop an US-guided BBB opening system capable of steering the US beam throughout the rodent brain and registering the coordinates with high field MRI. Our ultimate goal is to deliver therapy for Angelman Syndrome which requires the ability to deliver protein or adeno-associated virus (AAV) across the BBB over a large field of view. We sought to interface a modular imaging and therapeutic array capable of 3D electronic steering of the therapeutic beam to the Verasonics and MRI.

UR - http://www.scopus.com/inward/record.url?scp=85039428209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039428209&partnerID=8YFLogxK

U2 - 10.1109/ULTSYM.2017.8092098

DO - 10.1109/ULTSYM.2017.8092098

M3 - Conference contribution

BT - 2017 IEEE International Ultrasonics Symposium, IUS 2017

PB - IEEE Computer Society

ER -